Practical Considerations for the Use of Circulating Tumor DNA in the Treatment of Patients with Cancer

Investigators present a practical overview for selection of the most appropriate liquid biopsy assay, specifically focusing on circulating tumor DNA and how it may affect patient treatment and case management across multiple tumor types.